Background: The role of des-γ-carboxy prothrombin (DCP) in patients undergoing
radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) needs to be clarified …

BACKGROUND: Currently, surgical resection is considered the first‐line treatment for early
stage hepatocellular carcinoma (HCC). Radiofrequency ablation (RFA) has been an …

Abstract Background & Aims We investigated whether pre‐or post‐ablation serum alpha‐
foetoprotein (AFP) and des‐gamma‐carboxy prothrombin (DCP) levels can predict …

PURPOSE: Serial α-fetoprotein (AFP) measurements are useful for assessing tumor
responses to numerous therapies for hepatocellular carcinoma (HCC). This study tested the …

Background Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …

Objective: This study was undertaken to assess the prognostic predictor in patients with
hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA). Methods: This study …

The aim of this study was to elucidate the importance of three tumor markers, α-fetoprotein
(AFP), Lens culinaris agglutinin A-reactive fraction of AFP (AFP-L3), and des-γ-carboxy …

The aim of the present study was to predict the effects of transarterial infusion (TAI)
chemotherapy based on early changes in α‑fetoprotein (AFP) and des‑γ‑carboxy …

Abstract Background and Aim: The clinical utility of alpha‐fetoprotein (AFP) and des‐γ‐
carboxy prothrombin (DCP) as a predictor of treatment outcome in patients with advanced …

Background Des-γ-carboxy prothrombin (DCP) is a representative tumor marker of
hepatocellular carcinoma (HCC), and its values are occasionally very high in HCC cases …